HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 280, Issue 30, 27662-27669, July 29, 2005

This Article Full Text Full Text (PDF) All Versions of this Article: 280/30/27662    most recent M502593200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Belcheva, M. M. Articles by Coscia, C. J. Search for Related Content PubMed PubMed Citation Articles by Belcheva, M. M. Articles by Coscia, C. J. Social Bookmarking                      What's this?

µ and Opioid Receptors Activate ERK/MAPK via Different Protein Kinase C Isoforms and Secondary Messengers in Astrocytes^*

Mariana M. Belcheva, Amy L. Clark, Paul D. Haas, Jannie S. Serna, Jason W. Hahn, Alexi Kiss, and Carmine J. Coscia

From the E. A. Doisy Department of Biochemistry and Molecular Biology, St. Louis University School of Medicine, St. Louis, Missouri 63104

Acute µ and opioids activate the ERK/MAPK phosphorylation cascade that represents an integral part of the signaling pathway of growth factors in astrocytes. By this cross-talk, opioids may impact neural development and plasticity among other basic neurobiological processes in vivo. The µ agonist, [D-ala²,mephe⁴,glyol⁵]enkephalin (DAMGO), induces a transient stimulation of ERK phosphorylation, whereas agonist, U69,593, engenders sustained ERK activation. Here we demonstrate that acute U69,593 and DAMGO stimulate ERK phosphorylation by utilization of different secondary messengers and protein kinase C (PKC) isoforms upstream of the growth factor pathway. Immortalized astrocytes transfected with either antisense calmodulin (CaM), a mutant µ opioid receptor that binds CaM poorly or a dominant negative mutant of PKC were used as a model system to study µ signaling. Evidence was gained to implicate CaM and PKC in DAMGO stimulation of ERK. DAMGO activation of PKC and/or ERK was insensitive to selective inhibitors of Ca²⁺ mobilization, but it was blocked upon phospholipase C inhibition. These results suggest a novel mechanism wherein, upon DAMGO binding, CaM is released from the µ receptor and activates phospholipase C. Subsequently, phospholipase C generates diacylglycerides that activate PKC. In contrast, U69,593 appears to act via phosphoinositide 3-kinase, PKC, and Ca²⁺ mobilization. These signaling components were implicated based on studies with specific inhibitors and a dominant negative mutant of PKC. Collectively, our findings on acute opioid effects suggest that differences in their mechanism of signaling may contribute to the distinct outcomes on ERK modulation induced by chronic µ and opioids.

Received for publication, March 8, 2005 , and in revised form, June 7, 2005.

^* This work was supported in part by National Institutes of Health Grant DA05412. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, St. Louis University School of Medicine, 1402 S. Grand Blvd., St. Louis, MO 63104. Tel.: 314-977-9254; Fax: 314-977-9205; E-mail: cosciacc{at}slu.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				H. Zheng, H. H. Loh, and P.-Y. Law -Arrestin-Dependent {micro}-Opioid Receptor-Activated Extracellular Signal-Regulated Kinases (ERKs) Translocate to Nucleus in Contrast to G Protein-Dependent ERK Activation Mol. Pharmacol., January 1, 2008; 73(1): 178 - 190. [Abstract] [Full Text] [PDF]

				M. R. Bruchas, B. B. Land, M. Aita, M. Xu, S. K. Barot, S. Li, and C. Chavkin Stress-Induced p38 Mitogen-Activated Protein Kinase Activation Mediates {kappa}-Opioid-Dependent Dysphoria J. Neurosci., October 24, 2007; 27(43): 11614 - 11623. [Abstract] [Full Text] [PDF]

				M. R. Bruchas, T. Yang, S. Schreiber, M. DeFino, S. C. Kwan, S. Li, and C. Chavkin Long-Acting {kappa} Opioid Antagonists Disrupt Receptor Signaling And Produce Noncompetitive Effects By Activating C-Jun N-Terminal Kinase J. Biol. Chem., October 12, 2007; 282(41): 29803 - 29811. [Abstract] [Full Text] [PDF]

				Z.-Q. Zhao, Y.-J. Gao, Y.-G. Sun, C.-S. Zhao, R. W. Gereau IV, and Z.-F. Chen Central serotonergic neurons are differentially required for opioid analgesia but not for morphine tolerance or morphine reward PNAS, September 4, 2007; 104(36): 14519 - 14524. [Abstract] [Full Text] [PDF]

				R. Rozenfeld and L. A. Devi Receptor heterodimerization leads to a switch in signaling: {beta}-arrestin2-mediated ERK activation by {micro}-{delta} opioid receptor heterodimers FASEB J, August 1, 2007; 21(10): 2455 - 2465. [Abstract] [Full Text] [PDF]

				M. Xu, M. R. Bruchas, D. L. Ippolito, L. Gendron, and C. Chavkin Sciatic Nerve Ligation-Induced Proliferation of Spinal Cord Astrocytes Is Mediated by {kappa} Opioid Activation of p38 Mitogen-Activated Protein Kinase J. Neurosci., March 7, 2007; 27(10): 2570 - 2581. [Abstract] [Full Text] [PDF]

				E. Kim, A. L. Clark, A. Kiss, J. W. Hahn, R. Wesselschmidt, C. J. Coscia, and M. M. Belcheva {micro}- and {kappa}-Opioids Induce the Differentiation of Embryonic Stem Cells to Neural Progenitors J. Biol. Chem., November 3, 2006; 281(44): 33749 - 33760. [Abstract] [Full Text] [PDF]

				J. R. Parkitna, I. Obara, A. Wawrzczak-Bargiela, W. Makuch, B. Przewlocka, and R. Przewlocki Effects of Glycogen Synthase Kinase 3beta and Cyclin-Dependent Kinase 5 Inhibitors on Morphine-Induced Analgesia and Tolerance in Rats J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 832 - 839. [Abstract] [Full Text] [PDF]

				M. R. Bruchas, T. A. Macey, J. D. Lowe, and C. Chavkin Kappa Opioid Receptor Activation of p38 MAPK Is GRK3- and Arrestin-dependent in Neurons and Astrocytes J. Biol. Chem., June 30, 2006; 281(26): 18081 - 18089. [Abstract] [Full Text] [PDF]